A randomised controlled trial of the effects of a web based Prostate Specific Antigen decision explorer, Prosdex
Completed
- Conditions
- PSA decision aids, prostate cancerCancerProstate cancer
- Registration Number
- ISRCTN48473735
- Lead Sponsor
- Cardiff University (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Male
- Target Recruitment
- 600
Inclusion Criteria
Men between ages of 50 and 75
Exclusion Criteria
1. Previous PSA test or prostate cancer
2. Inability to access internet
3. Men who are known to be unable to read English
4. Serious uncontrolled medical conditions or concurrent medical illness likely to compromise life expectancy
5. Severe mental illness or dementia
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knowledge of PSA and prostate cancer-related issues: this will be assessed using a set of knowledge questions, used in an earlier evaluation of a brief paper-based leaflet about PSA testing, which showed an ability to discriminate between intervention and control groups. <br><br>The primary outcome, knowledge, will be measured immediately after the intervention: that is, men will be directed, automatically, from the Prosdex website to the online questionnaire. Men in the second intervention group and the first control group will also be asked at T0 to log onto the online questionnaire.
- Secondary Outcome Measures
Name Time Method